US considers doubling AIDS funding plan to $30bn:
This article was originally published in Clinica
The Global Fund to Fight AIDS, Tuberculosis and Malaria has welcomed US proposals to extend the President's Emergency Plan for AIDS Relief (PEPFAR) for a further five years, doubling the fund to $30bn. The timing is seen as particularly important as setting an international funding commitment standard ahead of the G8 summit. Only 2.2 million of the 6 million people with AIDS in the developing world receive treatment, says the Global Fund. For the World Health Organization, however, there is a far greater diagnostic need that relies on intensifying community-wide screening, and has launched an initiative to tackle this.
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.